This study evaluated different dosages of a monoclonal antibody given intravenously and subcutaneously in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018. Data analysis is underway.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit